GeoVax Labs Inc is a biotechnology business based in the US. GeoVax Labs shares (GOVX) are listed on the NASDAQ and all prices are listed in US Dollars. GeoVax Labs employs 7 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in GeoVax Labs
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GOVX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
GeoVax Labs stock price (NASDAQ: GOVX)Use our graph to track the performance of GOVX stocks over time.
GeoVax Labs shares at a glance
|Latest market close||$3.92|
|52-week range||$2.56 - $8.71|
|50-day moving average||$4.56|
|200-day moving average||$4.83|
|Wall St. target price||$10.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.18|
Buy GeoVax Labs shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy GeoVax Labs stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
GeoVax Labs price performance over time
|1 week (2021-10-15)||0.77%|
|1 month (2021-09-23)||-10.30%|
|3 months (2021-07-23)||-6.67%|
|6 months (2021-04-23)||-17.47%|
|1 year (2020-10-22)||28.95%|
|2 years (2019-10-22)||301,438.46%|
|3 years (2018-10-22)||15,706.45%|
|5 years (2016-10-21)||4,874.62%|
GeoVax Labs financials
|Gross profit TTM||$-620,801|
|Return on assets TTM||-29.03%|
|Return on equity TTM||-54.34%|
|Market capitalisation||$24.6 million|
TTM: trailing 12 months
Shorting GeoVax Labs shares
There are currently 432,835 GeoVax Labs shares held short by investors – that's known as GeoVax Labs's "short interest". This figure is 80.9% up from 239,273 last month.
There are a few different ways that this level of interest in shorting GeoVax Labs shares can be evaluated.
GeoVax Labs's "short interest ratio" (SIR)
GeoVax Labs's "short interest ratio" (SIR) is the quantity of GeoVax Labs shares currently shorted divided by the average quantity of GeoVax Labs shares traded daily (recently around 1.1 million). GeoVax Labs's SIR currently stands at 0.41. In other words for every 100,000 GeoVax Labs shares traded daily on the market, roughly 410 shares are currently held short.
To gain some more context, you can compare GeoVax Labs's short interest ratio against those of similar companies.
However GeoVax Labs's short interest can also be evaluated against the total number of GeoVax Labs shares, or, against the total number of tradable GeoVax Labs shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case GeoVax Labs's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 GeoVax Labs shares in existence, roughly 70 shares are currently held short) or 0.0712% of the tradable shares (for every 100,000 tradable GeoVax Labs shares, roughly 71 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against GeoVax Labs.
Find out more about how you can short GeoVax Labs stock.
GeoVax Labs share dividends
We're not expecting GeoVax Labs to pay a dividend over the next 12 months.
You may also wish to consider:
- Gilead Sciences (GILD.US) (4.08% forward annual dividend yield)
Have GeoVax Labs's shares ever split?
GeoVax Labs's shares were split on a 1:20 basis on 24 September 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your GeoVax Labs shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for GeoVax Labs shares which in turn could have impacted GeoVax Labs's share price.
GeoVax Labs share price volatility
Over the last 12 months, GeoVax Labs's shares have ranged in value from as little as $2.56 up to $8.71. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while GeoVax Labs's is 1.9069. This would suggest that GeoVax Labs's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put GeoVax Labs's beta into context you can compare it against those of similar companies.
GeoVax Labs overview
GeoVax Labs, Inc. , a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against coronavirus (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; the HIV Vaccines Trial Network; Centers for Disease Control and Prevention; U. S. Department of Defense; U. S.
GeoVax Labs in the news
GeoVax Chief Scientific Officer to Participate in World Vaccine Congress Europe
GeoVax Labs : Chief Scientific Officer to Participate in World Vaccine Congress Europe
GeoVax Chief Scientific Officer to Participate in World Vaccine Congress Europe
Frequently asked questionsWhat percentage of GeoVax Labs is owned by insiders or institutions?
Currently 8.306% of GeoVax Labs shares are held by insiders and 7.863% by institutions. How many people work for GeoVax Labs?
Latest data suggests 7 work at GeoVax Labs. When does the fiscal year end for GeoVax Labs?
GeoVax Labs's fiscal year ends in December. Where is GeoVax Labs based?
GeoVax Labs's address is: 1900 Lake Park Drive, Smyrna, GA, United States, 30080 What is GeoVax Labs's ISIN number?
GeoVax Labs's international securities identification number is: US3736785078 What is GeoVax Labs's CUSIP number?
GeoVax Labs's Committee on Uniform Securities Identification Procedures number is: 238326102
More guides on Finder
How to buy ProShares Bitcoin Strategy ETF (BITO)
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
How to buy The Real Good Food Company (RGF) stock when it goes public
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
How to buy Lulu’s Fashion Lounge Holdings (LVLU) stock when it goes public
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
How to buy Allarity Therapeutics (ALLR) stock when it goes public
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
How to buy Jupiter Neurosciences (JUNS) stock when it goes public
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
How to buy Mainz Biomed (MYNZ) stock when it goes public
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
How to buy Progressive Care stock when it goes public
Everything we know about the Progressive Care IPO, plus information on how to buy in.
How to buy Desert Peak Minerals (DPM) stock when it goes public
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
How to buy Vaxxinity (VAXX) stock when it goes public
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
How to buy Entrada Therapeutics (TRDA) stock when it goes public
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
Ask an Expert